IMMUNOVANT INC (IMVT) Institutional Ownership

IMVT is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $7.10M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $4.78M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's IMVT position is now estimated to be worth approximately $6.68M, representing an estimated gain of +39.73% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Greenlight Capital, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward IMMUNOVANT INC (IMVT).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20262$7,104,736286,020
Q2 20251$3,862,400241,400
Q1 20252$25,818,3241,510,727
Q4 20242$36,862,4661,488,190
Q3 20242$71,557,3062,509,902
Q2 20242$71,517,6532,709,002
Q1 20242$58,465,3232,148,872
Q4 20231$77118,300
Q3 20231$8,500221,400
Q2 20231$8,874467,800
Q1 20231$7,633492,112
Q4 20221$6,108344,100